Device Trial Radar
Methods & limitations
Last checked: Nov 19, 2026ClinicalTrials.gov last updated: Nov 19, 2026
Where the data comes from
Everything here comes from ClinicalTrials.gov, the public registry run by the US National Library of Medicine. We read it through the registry's public data service (API version 2) each time a page is requested and keep a copy of each answer for up to six hours. We do not keep our own database of trials, and we do not edit, score or add to the records.
Sponsors and investigators enter and update their own records. The registry checks them for completeness, but it does not verify that what a sponsor wrote is accurate or current.
Which trials are included
- A trial is included when its registry record lists at least one intervention of type "Device". A study that combines a device with a drug or a procedure is included. A device study that the sponsor filed under another intervention type is missed.
- The default view shows trials that are recruiting and whose lead sponsor the registry classes as industry. Both defaults can be changed in the filters. Sponsor class is assigned by the registry, and some companies are classed as "Other".
- Trial status is the overall status the sponsor last reported. "Any status" also includes suspended, terminated, withdrawn and unknown-status trials.
- Sponsor name matches the lead sponsor as a phrase. Collaborators are not searched, and a company that files under several legal names needs a search for each one.
- Start date and enrollment filters use the sponsor's figures, which are often estimates until the trial finishes.
Specialties
The registry does not label trials by medical specialty. Each specialty here is a saved search, usually on the conditions being studied (using the registry's own condition groupings) and sometimes on the name of the device. That means a trial can show up under more than one specialty, and some trials that belong to a specialty will be missed. Treat the specialty filter as a good starting list, not a complete one.
The "pivotal-looking" flag
A pivotal trial is the study a company intends to rely on for marketing approval or clearance. The registry has no field for that, and neither FDA nor the sponsor labels trials this way in the data we read. The flag is our own rule of thumb. A trial is marked pivotal-looking when either of these is true:
- the word "pivotal" appears in its brief or official title, or
- it is randomized and has an enrollment (planned or actual) of 100 or more participants.
We chose 100 participants as the cutoff because randomized device studies below that size are usually feasibility or pilot work. It is a judgment call, not an industry standard.
The rule gets things wrong in both directions:
- It flags large randomized studies that are not meant to support a marketing submission, such as post-market studies and comparisons of devices already on the market.
- It misses real pivotal studies that are single-arm (common for devices measured against a performance goal) or small (common in rare conditions), unless the title says "pivotal".
Each flagged trial shows which part of the rule it met. To know whether a trial is truly pivotal, read the registry record and the sponsor's own statements.
Trials near you
- A US ZIP code is converted to a single point (roughly the middle of the ZIP code area) using the free Zippopotam.us lookup. The ZIP code you enter is sent to that service and appears in the page address. Nothing else about you is sent.
- The registry then returns trials with at least one site within the chosen straight-line distance of that point. Driving distance will be longer.
- The status filter applies to the trial as a whole. A nearby site may be closed, or not yet open, while the trial is listed as recruiting. Check the status of the specific site.
- The "nearest site" shown on a result is our own distance calculation from the site coordinates the registry provides.
Sponsor labels
For industry sponsors we check the name against a short, hand-kept list of 48 publicly traded device companies and show the ticker when there is a match. "Not on our public-company list" means only that: the company may be private, may be public and missing from our list, or may be a subsidiary filing under a name we do not recognize. The list can also be out of date after a merger or a company going private.
What we leave out
- Names, emails and phone numbers of investigators, study staff and site contacts are not requested from the registry and are not shown. Use the registry record to contact a study.
- Site lists on a trial page are capped. The full list is on the registry record.
- Eligibility criteria, secondary outcomes, arms and posted results are not shown. Follow the link to the registry record.
Other limitations
- Not every device study is registered. US law requires registration for most controlled studies of FDA-regulated devices, but small feasibility studies are exempt and many are never listed.
- Records can be stale. A trial may show as recruiting long after enrollment closed if the sponsor has not updated it.
- Counts are counts of registry records. One device program can have several records, and one record can cover many sites and countries.
- A registered trial says nothing about whether a device works, is safe, or will be cleared or approved. It is not a measure of a company's prospects.
- Pages can be up to six hours behind the registry. The "latest source record" stamp shows the newest update on the page.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.